Radioimmunotherapy with 131I-anti-CD20 rituximab in B-cell lymphoma: Results of the goettingen RAIT study group.
2002 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Radioimmunotherapy with 131I-anti-CD20 rituximab in B-cell lymphoma: Results of the goettingen RAIT study group.
Griesinger, F.; Behr, T.; Jung, W.; Glass, B.; Truemper, L. H.; Meller, J. & Woermann, B. et al. (2002)
Blood, 100(11) 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA.
Washington: Amer Soc Hematology.
Documents & Media
Details
- Authors
- Griesinger, Frank; Behr, T.; Jung, Werner; Glass, Bertram; Truemper, Lorenz H.; Meller, J.; Woermann, Bernhard; Kaufmann, C. C.; Binder, Claudia; Brittinger, G.; Becker, W.
- Issue Date
- 2002
- Status
- published
- Publisher
- Amer Soc Hematology
- Journal
- Blood
- Conference
- 44th Annual Meeting of the American-Society-of-Hematology
- Conference Place
- PHILADELPHIA, PENNSYLVANIA
- ISSN
- 0006-4971
- Extent
- 313B
